David McCullough, VP at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 60,624 shares at $2.45 ($149K) on 2012-01-03, disclosed to the SEC on 2012-01-05.
Scheduled sale ($149k) by VP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2010-01-25 | $100K | — | Filing → |